Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUET II urokinase dose comparison in acute and sub-acute infra-inguinal arterial or bypass graft thrombosis
NL-OMON44501Suspended
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Oct 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of urokinase in peripheral arterial thrombosis, bypass graft thrombosis and Acute limb ischaemia (ALI) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Occurrence of hemorrhagic complications. Started Oct 2016; status: suspended.
02
Drugs
urokinase
03
Conditions
peripheral arterial thrombosisbypass graft thrombosisAcute limb ischaemia (ALI)
Beyond the preview
Go deeper on NL-OMON44501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44501.